Regeneron Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (78)

Latest Posts

About This Stock More About This Stock
Best Biotech Stocks To Buy In 2022
Article By: Elliottwave Forecast
Tuesday, March 15, 2022 6:42 AM EDT
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and pharmaceuticals, genomics, and food and chemical manufacturing.
In this article: BMY, JNJ, PFE, NVAX, REGN, AMGN, VRTX, AXSM, GMAB, RLAY
Read
S Earnings Review: F5 Inc., Regeneron Inc.
Article By: Ingrid Hendershot
Monday, March 14, 2022 5:13 AM EDT
F5 reported fiscal first quarter revenues increased 10% to $687 million with net income and EPS increasing 7%. Regeneron reported fourth quarter sales more than doubled to $5 billion with net income and EPS each up.
In this article: FFIV, REGN Also: CNI, FDS, GD, GPC, HRL, JNJ, MA, MMM, MMS, NKE, PEP, SYK, TJX, UNH, UPS, CSCO, CTSH, FAST, GNTX, INTC, MSFT, PAYX, ROST, SBUX, SEIC, TROW, TSCO, BF-B, RTX
Read
3 Cathie Wood Stocks To Buy On The Dip
Article By: StockNews
Saturday, December 25, 2021 5:00 PM EDT
Institutional investor Cathie Wood gained popularity after her ETFs generated big gains last year. Wood asserted recently that her stocks are poised for long-term gains. Hence, we think investing in Wood’s portfolio stocks might be profitable.
In this article: REGN, TRMB, VRTX Also: SNY, SPY, ARKK
Read
4 Low-Beta Stocks To Buy For A Volatile Market
Article By: StockNews
Wednesday, December 8, 2021 5:00 PM EDT
Global economic uncertainty, inflationary pressure, a disappointing jobs report, and concerns around the COVID-19 Omicron variant are fostering market volatility. So, against this backdrop, we think it would be wise to bet on these low-beta stocks.
In this article: CAJ, RMD, REGN, ERIC
Read
S Tuesday Talk: Up But Under 4500
Article By: TalkMarkets DailyTalk
Tuesday, September 14, 2021 8:11 AM EDT
Both the S&P 500 and the Dow closed higher on Monday to end their five day losing streak, while the Nasdaq closed slightly lower than it's Friday close. Closing at 4,469 the S&P 500 was up 10 points but still well below the 4,500 mark.
In this article: ACN, BOH, MA, NKE, REGN, AAPL, INTC, ORCL, ULTA, GOOGL Also: DB, MRNA, NDX
Read

Latest Tweets for $REGN

No tweets yet!

PARTNER HEADLINES

$REGN

Regeneron Pharmaceuticals’ Dupixent Has Multi-Billion-Dollar Potential: Polen Capital
David J. Tanner 1/31/2018 3:55:05 AM

Note it has only been approved in Japan. And only for those whom existing treatments are ineffective. So that's a MUCH smaller market. How small I don't know. But not enough to make me bite. $REGN

1 to 1 of 1 comments